Bevacizumab
SB8-G31-NSCLC
Phase 3 small_molecule completed
Quick answer
Bevacizumab for Lung Cancer is a Phase 3 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed